27 September 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st September 2022. In addition to the studies identified from June 2021 to August 2022, we found two records linked to previously identified studies. We will incorporate these into the review as part of a future update. |
17 August 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st August 2022. In addition to the studies identified from June 2021 to July 2022, we found two new included studies, 1 new ongoing study and 3 records linked to previously identified studies. The DOIs for the 2 new included studies are: Coffey 2020 (DOI: 10.1177/1757913920912436) and Price 2022 (DOI: https://doi.org/10.1186/s12889-022-13711-x). We will incorporate these into the review as part of a future update. |
8 July 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st July 2022. In addition to the studies identified from June 2021 to June 2022, we found four new included studies, 1 new ongoing study and 8 records linked to previously identified studies. The DOIs for 3 of the new included studies are: Edmiston 2022 (DOI: 10.1093/ntr/ntac029); Tattan‐Birch 2022 (DOI: 10.1093/ntr/ntac149) and Morphett 2022a (DOI: 10.1093/ntr/ntab266). The fourth new included study was presented at SRNT 2022 (abstract reference: SYM17‐4). We will incorporate these into the review as part of a future update. |
15 June 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st June 2022. In addition to the studies identified from June 2021 to May 2022, we found three new included studies (all previously listed as ongoing studies) and 2 records linked to a previously identified study. The DOIs for the new included studies are: Hajek 2022 (https://doi.org/10.1038/s41591-022-01808-0); Bonafont Reyes 2022 (https://doi.org/10.1111/jgs.17755) and Vickerman 2022 (https://doi.org/10.1093/ntr/ntac129). We will incorporate these into the review as part of a future update. |
6 May 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st May 2022. In addition to the studies identified from June 2021 to April 2022, we found two new included studies (previously listed as ongoing studies), 3 new ongoing studies and 2 records linked to previously identified studies. The DOIs for the new included studies are: Skelton 2022 (doi: 10.1016/j.addbeh.2022.107328); Pratt 2022 (doi: 10.1093/ntr/ntac082). We will incorporate these into the review as part of a future update. |
6 April 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st April 2022. In addition to the studies identified from June 2021 to March 2022, we found 4 new ongoing studies. We will incorporate these into the review as part of a future update. |
7 March 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st March 2022. In addition to the studies identified from June 2021 to February 2022, we found 1 record linked to a study already identified as ongoing. We will incorporate these into the review as part of a future update. |
11 February 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st February 2022. In addition to the studies identified from June 2021 to January 2022, we found 2 ongoing studies and 2 records linked to studies already included in the review. We will incorporate these into the review as part of a future update. |
12 January 2022 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st January 2022. In addition to the studies identified from June to December 2021, we found 4 ongoing studies and 1 record linked to a study already included in the review. We will incorporate these into the review as part of a future update.[Enter text here] |
16 December 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date: 1st December 2021. In addition to the studies identified from June to November 2021, we found six new included studies, 15 ongoing studies and 18 records linked to studies already included in the review. The DOI or trial IDs for the new included studies are: NCT02433015; NCT03111537; NCT03185546; NCT03358953; Caponnetto 2021 (DOI: 10.1093/ntr/ntab005); Lum 2021 (DOI: 10.1016/j.addbeh.2021.107097). We will incorporate these into the review as part of a future update. |
3 November 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st November 2021. In addition to the studies identified from June to October 2021, we found one new included study. The DOI for the new included study (Okuyemi 2021) is 10.1093/ntr/ntab212. We will incorporate these into the review as part of a future update. |
20 October 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st October 2021. In addition to the studies identified from June to September 2021, we found one new included study two reports linked to studies already in the review, and one new ongoing. The DOI for the new included study (Morris 2021) is https://doi.org/10.1007/s11739-021-02813-w. We will incorporate these into the review as part of a future update. |
16 September 2021 |
Amended |
Change made to correct data; SAE data from Cobb 2021 moved from comparison with NRT to comparison with no‐nicotine EC. No changes to conclusions. |
6 September 2021 |
New citation required and conclusions have changed |
New secondary outcome added (continued product use), first study of pod device contributing data to cessation meta‐analysis added, two new comparisons added (nicotine salt EC versus freebase nicotine EC; advice on how to quit smoking using EC versus no EC advice). Conclusions for primary outcomes remain largely unchanged. |
6 September 2021 |
New search has been performed |
This is a Living Systematic Review. We run and screen searches monthly. Last search update 1st September 2021. We found no new studies for inclusion this month; however results from searches carried out from June to August 2021 will be incorporated into a future update of the review. |
6 September 2021 |
New search has been performed |
Updated with five new included studies. Incorporates evidence up to 1 May 2021. |
5 August 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 2nd August 2021. In addition to the studies identified from March to July 2021, we found two new ongoing studies and one report linked to a study already in the review. We will incorporate these into the review as part of a future update. |
7 July 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st July 2021. In addition to the studies identified from March to June 2021, we found two new included studies and two reports linked to studies already in the review. DOIs for the two new included studies are as follows: Myers‐Smith 2021: https://doi.org/10.1111/add.15628 & Kimber 2021: 10.1016/j.addbeh.2021.106909. We will incorporate these into the review as part of a future update. |
9 June 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st June 2021. In addition to the studies identified from March to May 2021, we found one report linked to a study already in the review, one ongoing study, and one potentially new study that we are looking into further. We will incorporate these into the review as part of a future update. As part of this new update we will also include a new outcome ‐ proportion of people still using e‐cigarettes or other pharmacotherapy at longest follow‐up. |
12 May 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 4th May 2021. In addition to the studies identified from March and April 2021, we found four new ongoing studies. We will incorporate these into the review as part of a future update. |
15 April 2021 |
New citation required and conclusions have changed |
6 new included studies added (Czoli 2019; Ikonomidis 2020a; Ozga‐Hess 2019; Pulvers 2020; Scheibein 2020; Yingst 2020), certainty in finding of no difference in adverse events between nicotine EC and non‐nicotine EC updated to moderate (from low). First study of pod EC device included. |
15 April 2021 |
New search has been performed |
Updated with six new included studies and new data from one previously included study. Most recent search 1 Feb 2021. |
1 April 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st April 2021. In addition to the studies identified from March 2021 we found two new ongoing studies and one paper linked to a study already included in the review. We will incorporate these into the review as part of a future update. |
17 March 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st March 2021. Studies identified in March are not included in this version of the review, but will be incorporated into a subsequent version. We found four new included studies, five new ongoing studies and five papers linked to studies already included in the review. The four new included studies were all conference abstracts; three of which were identified from the SRNT 2021 abstract book (SYM2A, SYM2B, PH‐353; www.srnt.org/page/2021_Meeting). The fourth is available here: dx.doi.org/10.1016/j.drugalcdep.2015.07.1091. |
4 February 2021 |
Amended |
This is a Living Systematic Review. We run and screen searches monthly. Last search date 1st February 2021. In addition to the studies identified from our December 2020 and January 2021 searches we found one paper linked to a study already included in the review (Lucchiari 2020), and have preliminary results from a study listed as ongoing (Begh 2021). We will incorporate this paper and data into the review as part of a future update. |
20 January 2021 |
Amended |
This is a Living Systematic Review. Searches are run and screened monthly. Last search date 4th January 2021. In addition to the studies identified from our December 2020 searches we found four new completed studies, one new ongoing study and one paper linked to a study already included in the review. These studies and papers will be incorporated into the review at the next update. DOIs for the four new included studies are as follows: Ozga‐Hess et al. 2019: 10.1016/j.addbeh.2019.106105; Pulvers et al. 2020: 10.1001/jamanetworkopen.2020.26324; Scheibein 2020: 10.1186/s12954-020-00406-y; Yingst et al. 2020: 10.1080/09540121.2019.1687835
|
15 December 2020 |
Amended |
This is a Living Systematic Review. Searches are run and screened monthly. Last search date 1st December 2020. Searches found 3 new completed studies, 11 new ongoing studies and 9 papers linked to studies already included in the review. These studies and papers will be incorporated into the review at the next update. DOIs for the three new included studies are as follows: Czoli et al:10.1093/ntr/nty174;Bonevski et al: 10.1093/ntr/ntaa143;Eisenberg et al: 10.1001/jama.2020.18889.
|
20 July 2020 |
New citation required and conclusions have changed |
Strength of evidence increased for existing comparisons; new comparisons added |
20 July 2020 |
New search has been performed |
New searches run January 2020. 35 new studies added. Living systematic review protocol incorporated |
14 December 2016 |
Amended |
Clarification on outcome data from Adriaens ‐ no changes to conclusions |
23 June 2016 |
New search has been performed |
Update search run January 2016, 11 new included studies added. Reduction removed as outcome, now covered in Harm Reduction review. |
23 June 2016 |
New citation required but conclusions have not changed |
11 new included studies added; no changes to conclusions. |